Companies: 10,795·Total market cap: $144.5T
Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNSNASDAQHealthcare● Active
$0.23
$-0.00(-0.65%)
Market Cap$8362057
P/E Ratio
52W High$3.33
52W Low$0.172

Jupiter Neurosciences, Inc. (JUNS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

juns · pe ratio · data through Jun 9, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

PE Ratio vs Peers

Biotechnology · 5 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc.You
JUNS
$8MN/A
Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc.
ALGS
$32MN/A-$2.45
FibroGen, Inc.
FibroGen, Inc.
FGEN
$37M0.19x$45.38
Genenta Science S.p.A.
Genenta Science S.p.A.
GNTA
$35MN/A-$0.32
Grace Therapeutics, Inc.
Grace Therapeutics, Inc.
GRCE
$37MN/A-$1.13
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc.
KZR
$54MN/A-$7.66

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Jupiter Neurosciences, Inc. (JUNS) measures how much investors pay for each dollar of the company's trailing earnings. JUNS's current PE ratio of N/A is calculated by dividing its stock price of $0.23 by its TTM earnings per share of —.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.23 ÷ — = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

JUNS pe ratio · 6 questions

JUNS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.23 and TTM EPS of —. Data sourced from Financial Modeling Prep via JUNS's SEC 10-K and 10-Q filings.

JUNS PE ratioWhat is JUNS PE ratioCurrent PE ratio of JUNSJUNS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Jupiter Neurosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09